The global pacemaker market size is expected to reach USD 7.7 billion by 2030. The market is projected to grow at a CAGR of 5.7% from 2025 to 2030. The market is experiencing steady growth, driven by advancements in medical technology and an increasing global demand for heart rhythm management solutions. Technological innovations, such as leadless pacemakers, smaller devices, and improved battery life, have significantly enhanced the effectiveness and convenience of pacemaker implantation. Integrating remote monitoring capabilities has also improved patient care by allowing healthcare providers to track pacemaker function and patient health remotely, reducing hospital visits. In November 2024, Europe witnessed its first single-chamber, wireless cardiac pacemaker implantation at Bern University Hospital. This procedure, led by experts from the UAE, underscores the country's position as a leader in medical innovation and its commitment to training regional healthcare professionals.
The market benefits from a greater focus on treating heart conditions such as bradycardia, arrhythmias, and heart failure. As cardiovascular diseases remain one of the leading causes of death globally, the need for reliable and effective pacing devices continues to rise. Pacemakers are increasingly seen as a critical solution for improving patient outcomes, leading to their widespread adoption in hospitals and outpatient centers. With continuous advancements in pacemaker technology and a growing demand for cardiac care, the market is expected to maintain strong growth in the coming years. In November 2023, MedStar Washington Hospital Center became one of the first institutions in the U.S. to offer the Aveir DR Leadless Pacemaker System for patients with abnormally slow heart rates.
This product will be delivered within 1-3 business days.
The market benefits from a greater focus on treating heart conditions such as bradycardia, arrhythmias, and heart failure. As cardiovascular diseases remain one of the leading causes of death globally, the need for reliable and effective pacing devices continues to rise. Pacemakers are increasingly seen as a critical solution for improving patient outcomes, leading to their widespread adoption in hospitals and outpatient centers. With continuous advancements in pacemaker technology and a growing demand for cardiac care, the market is expected to maintain strong growth in the coming years. In November 2023, MedStar Washington Hospital Center became one of the first institutions in the U.S. to offer the Aveir DR Leadless Pacemaker System for patients with abnormally slow heart rates.
Pacemaker Market Report Highlights
- The implantable pacemaker segment dominated the product category in 2024 with 68.0% of the market share due to its proven effectiveness in treating heart rhythm disorders and widespread adoption in clinical practice.
- In 2024, the bradycardia segment accounted for a substantial share of 27.5% by application owing to the high prevalence of bradycardia, particularly among aging populations.
- In terms of end use, the hospital segment dominated in 2024 due to the advanced healthcare infrastructure and specialized care available in hospital settings. Outpatient facilities are anticipated to grow at the fastest CAGR owing to the increasing adoption of minimally invasive procedures and shorter recovery times.
- North America held the largest share of 43.4% of the global market due to advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative pacemaker technologies.
- Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to rising cardiovascular disease prevalence, improving healthcare access, and increasing healthcare investments in the region.
- The competition features key players implementing strategies like product launches, distribution agreements, and strategic partnerships, which have greatly expanded their market share.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Pacemaker Market Variables, Trends & Scope
Chapter 4. Pacemaker Market: Product Estimates & Trend Analysis
Chapter 5. Pacemaker Market: Application Estimates & Trend Analysis
Chapter 6. Pacemaker Market: End Use Estimates & Trend Analysis
Chapter 7. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country, Product, Application, and End-use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- OSYPKA MEDICAL
- Boston Scientific Corporation
- Zoll Medical Corporation, an Asahi Kasei Group Company
- Medtronic
- BIOTRONIK SE & Co. KG
- MicroPort Scientific Corporation
- MEDICO S.R.L.
- Shree Pacetronix Ltd.
- Abbott
- OSCOR Inc
- Lepu Medical Technology (Beijing) Co., Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 165 |
| Published | November 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 5.5 Billion |
| Forecasted Market Value ( USD | $ 7.7 Billion |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
